Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Mount Sinai to begin largest study of personalized medicine in clinical care setting

Mount Sinai School of Medicine has been awarded a $3.4 million grant over four years from the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) to begin the largest study of its kind, in which a patient's genomic risk for disease is revealed in a lab, and then entered into an electronic medical record for use in determining treatment in the clinical care setting.

19 Aug 2011

Conference to discuss latest research on gender disparities in cardiovascular disease

Heart disease has sometimes been considered a men's health issue, but the statistics prove otherwise. In the US alone, more than 42 million women live with the problem. Heart disease is responsible for more than one-third of deaths among American women each year, making it the number one killer of females older than 20.

19 Aug 2011

Temple University, URMC partner to translate novel medical research into new drugs

The University of Rochester Medical Center (URMC) and Temple University School of Pharmacy have announced a partnership that will help translate novel medical research into new drugs for treating diseases.

19 Aug 2011

Researchers demonstrate a way to control excitation and contraction in cardiac muscle cells

By employing optogenetics, a new field that uses genetically altered cells to respond to light, and a tandem unit cell (TCU) strategy, researchers at Stony Brook University have demonstrated a way to control cell excitation and contraction in cardiac muscle cells, the details of which are published in the early online edition of Circulation: Arrhythmia & Electrophysiology: "Stimulating Cardiac Muscle by Light: Cardiac Optogenetics by Cell Delivery."

19 Aug 2011

Bill Clinton on being ‘vegan’

Former President Bill Clinton has revealed that his diet is turning plant-based and heart-healthy. He said he believes the vegan regimen is helping to reverse the damage to his heart and blood vessels caused by cardiovascular disease.

18 Aug 2011

Medical research funding boost in UK

Health researchers in Cambridge have been awarded £114.5m to develop and translate new scientific discoveries into medicines and treatments. The funds come as a part of a five-year £800m investment by the National Institute for Health Research (NIHR).

18 Aug 2011

National analysis identifies Columbus as one of the Hypertension Hot Spots in the U.S.

A national analysis conducted by Sperling's BestPlaces and sponsored by Takeda Pharmaceuticals North America, Inc., identified Columbus, Ohio, as one of the nation's Hypertension Hot Spots, or cities that have hypertension risk factors and complications.

18 Aug 2011

Sepracor Pharmaceuticals changes company name to Sunovion

Sunovion Pharmaceuticals Canada Inc., formerly Sepracor Pharmaceuticals, Inc., announced today that it has formally changed its name.

18 Aug 2011

Just 15 minutes of exercise per day prolongs life

Taiwanese researchers reported Monday in the journal The Lancet that exercising for just 15 minutes most days of the week appears to provide health benefits by prolonging life.

17 Aug 2011

UCSD Sulpizio Cardiovascular Center receives ACCF/AHA's GWTG Gold award

UC San Diego Health System is one of only 167 hospitals nationwide to receive the American College of Cardiology Foundation's (ACCF) NCDR ACTION Registry-GWTG (Get with the Guidelines) Gold Performance Achievement Award for 2011.

17 Aug 2011

Scientists gain new insight on role of stem cells in embryonic heart development

Scientists at the Gladstone Institutes have gained new insight into the delicate relationship between two proteins that, when out of balance, can prevent the normal development of stem cells in the heart and may also be important in some types of cancer.

16 Aug 2011

Inflammation linked with RA increases patients risk of heart disease

Rheumatoid arthritis (RA) sufferers are at an increased risk of dying due to cardiovascular disease. A new five year study published in BioMed Central's open access journal Arthritis Research & Therapy showed that the risk of cardiovascular disease for people with RA is due to disease-related inflammation as well as the risk factors which affect the general population.

16 Aug 2011

Prolonged TV viewing linked with reduced life expectancy

Watching TV for an average of six hours a day could shorten the viewer's life expectancy by almost five years, indicates research published online in the British Journal of Sports Medicine.

16 Aug 2011

Pericardial fat may promote atherosclerosis

Researchers have found more evidence supporting the role of fat around the heart in promoting atherosclerosis, according to a study published online in the journal Radiology.

16 Aug 2011

EOSS could predict risk of death in overweight, obese people

A new tool - the Edmonton obesity staging system (EOSS) - improves on current methods to predict the risk of death in overweight and obese people, according to a study in CMAJ.

16 Aug 2011

Enrollment commences in Omthera's Epanova Phase III trial for hypertriglyceridemia

Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that the first patient has been enrolled in its ESPRIT Phase III clinical trial of Epanova, in patients with hypertriglyceridemia (TG level greater than or equal to 200 and < 500 mg/dL) despite treatment with a statin.

16 Aug 2011

An hour of TV a day shortens lifespan by 22 minutes: Study

Researchers have found that watching too much TV is as dangerous as smoking or being overweight, and that the “ubiquitous sedentary behaviour” should be seen as a “public health problem”.

16 Aug 2011

Toclizumab for juvenile rheumatoid arthritis

The arthritis drug Toclizumab could be a boon for hundreds of children suffering from severe arthritis. It has been re-launched in children after being already licensed for the treatment of adults. At least two thirds of children taking tocizilumab have been able to return to a normal life, after many were bedridden or forced into wheelchairs by the disease, the clinical studies reveal.

16 Aug 2011

Thorne acquires global rights to Q-Cell, an advanced formulation Coenzyme Q10

Thorne Research, Inc., a leader in developing and manufacturing pure, high quality nutritional supplements marketed through licensed healthcare practitioners, has acquired exclusive global rights to market Q-Cell, an advanced formulation Coenzyme Q10 (CoQ10) supplement formerly marketed under the brand name Q-Best.

12 Aug 2011

Fibrate drugs may not prevent heart attacks in diabetes patients with elevated cholesterol

Type 2 diabetes patients, who face higher risk of cardiovascular disease, often take a combination of medications designed to lower their LDL or "bad" cholesterol and triglyceride levels while raising their HDL or "good" cholesterol because doctors long have thought that taken together, the drugs offer protection from heart attacks and improve survival.

12 Aug 2011

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Mount Sinai to begin largest study of personalized medicine in clinical care setting

Conference to discuss latest research on gender disparities in cardiovascular disease

Temple University, URMC partner to translate novel medical research into new drugs

Researchers demonstrate a way to control excitation and contraction in cardiac muscle cells

Bill Clinton on being ‘vegan’

Medical research funding boost in UK

National analysis identifies Columbus as one of the Hypertension Hot Spots in the U.S.

Sepracor Pharmaceuticals changes company name to Sunovion

Just 15 minutes of exercise per day prolongs life

UCSD Sulpizio Cardiovascular Center receives ACCF/AHA's GWTG Gold award

Scientists gain new insight on role of stem cells in embryonic heart development

Inflammation linked with RA increases patients risk of heart disease

Prolonged TV viewing linked with reduced life expectancy

Pericardial fat may promote atherosclerosis

EOSS could predict risk of death in overweight, obese people

Enrollment commences in Omthera's Epanova Phase III trial for hypertriglyceridemia

An hour of TV a day shortens lifespan by 22 minutes: Study

Toclizumab for juvenile rheumatoid arthritis

Thorne acquires global rights to Q-Cell, an advanced formulation Coenzyme Q10

Fibrate drugs may not prevent heart attacks in diabetes patients with elevated cholesterol

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Newsletters you may be interested in